Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SAM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel convergent synthesis of Prisamod (CN111087357A). Achieve 31.6% total yield with reduced waste. A reliable API intermediate supplier solution.
Advanced post-processing technology reduces V320 and NDMA impurities in Valsartan manufacturing. Ensures supply chain safety and regulatory compliance for global pharmaceutical partners.
Patent CN104892674B details a high-purity ceftaroline fosamil preparation method eliminating complex purification, offering substantial cost reduction and supply chain reliability.
Novel one-pot method for Lacosamide improves purity and reduces steps significantly. Ideal for reliable pharmaceutical intermediate supplier partnerships seeking cost efficiency.
Novel one-pot synthesis for Lacosamide intermediates ensures high purity and reduced toxicity. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN116730849A reveals a high-yield enzymatic route for HIV inhibitor intermediates. Achieve superior purity and scalable supply chain reliability.
Patent CN117384226B details a high-purity GalNAc synthesis route offering significant cost reduction and supply chain reliability for oligonucleotide drug manufacturing.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.
Patent CN115010610B reveals high-purity miglitol intermediate synthesis with zero emission. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel catalytic hydrogenation process ensures high purity and yield for 1-amino-1-deoxy-D-glucitol manufacturing with significant supply chain cost advantages.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Improved transaminase catalysis for sitagliptin reduces solvent use and enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN103601706A details a novel L-Serine route for Jaspine B isomers. Achieve cost reduction in API manufacturing with high-purity sphingosine analogs.
Patented room temperature method reduces cost and improves supply chain reliability for high purity aldehyde intermediates used in pharmaceutical manufacturing globally.
Discover a novel, catalyst-free synthesis of N-nitrosamines using sulfonyl fluoride. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing with this green technology.
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.
Solve PF-07321332 synthesis challenges: 76%+ yield, 98% purity, mild conditions. Eliminate -78°C steps & column chromatography. Scale to 100MT/yr.
Achieve 60-90% yield in one step with readily available reagents. Eliminate complex purification and reduce costs for your sesamin precursor supply chain.
Solve sesamin precursor synthesis challenges with this rare earth metal method. 60-90% yield, air-stable operation, and reduced supply chain risks for pharma R&D and production.